Atlas Trials

AHSCT Combined With CAR-T Cells in the Treatment of Refractory and Relapsed Multiple Myeloma

Clinical trial NCT05740891 · UNKNOWN

Trial details

NCT number
NCT05740891
Sponsor
Zhejiang University
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Multiple Myeloma
Start date
2023-03-01
Primary completion
2025-03-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.